# Probiotic IBNI617 for Moderate to Severe Depression

> **NCT07728253** · NA · NOT_YET_RECRUITING · sponsor: **IBIOME BIOTECHNOLOGY CO., LTD** · enrollment: 148 (estimated)

## Conditions studied

- Major Depressive Disorder (MDD)
- IBNI617

## Interventions

- **OTHER:** Live biotherapeutic product
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07728253
- **Lead sponsor:** IBIOME BIOTECHNOLOGY CO., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-12
- **Final completion:** 2028-04
- **Target enrollment:** 148 (ESTIMATED)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07728253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07728253, "Probiotic IBNI617 for Moderate to Severe Depression". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07728253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*